FTC Announces Proposed Settlement with Texas Supplement Companies over Baseless Health Claims

Bernard Nash
Cozen O'Connor
Contact
LinkedIn
Facebook
X
Send
Embed

Cozen O'Connor

  • The FTC has announced a proposed settlement with Health Research Laboratories, LLC, Whole Body Supplements, LLC, and their owner (collectively, “Respondents”), over allegations that they made unsubstantiated claims that their supplements—The Ultimate Heart Formula, BG18, Black Garlic Botanicals, and Neupathic —prevent or treat cardiovascular and other diseases.
  • The administrative complaint alleged that the two companies violated the FTC Act by using deceptive printed promotional materials and online information to make unsubstantiated claims that their products could prevent and treat a range of diseases, including arterial plaque, high blood pressure, elevated cholesterol, and also that its supplement Neupathic could relieve neuropathy.
  • Under the terms of the proposed agreement, Respondents will be banned from marketing or promoting any dietary supplements, or represent that any product treats or cures diseases, and notify customers of both the FTC’s legal action and the lack of scientific support for their product claims.
Send Print Report

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Cozen O'Connor | Attorney Advertising

Written by:

Cozen O'Connor
Cozen O'Connor
Contact
more
less

PUBLISH YOUR CONTENT ON JD SUPRA NOW

  • Increased visibility
  • Actionable analytics
  • Ongoing guidance

Cozen O'Connor on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign Up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide